z-logo
open-access-imgOpen Access
Biologics in rheumatoid arthritis - recommendations for Swiss practice
Author(s) -
Jean Dudler,
Burkhard Möller,
BA Michel,
PM Villiger
Publication year - 2011
Publication title -
schweizerische medizinische wochenschrift
Language(s) - English
Resource type - Journals
ISSN - 0036-7672
DOI - 10.4414/smw.2011.13189
Subject(s) - medicine , rheumatoid arthritis , clinical practice , intensive care medicine , biologic agents , alternative medicine , antirheumatic agents , physical therapy , family medicine , pathology
The new paradigm of therapy in rheumatoid arthritis is to aim toward early and complete remission, using a larger use of conventional DMARDs and biologic agents. The present recommendations were established through a consensus to help practitioners in their daily use of those agents, to reflect the current "best practice" in Switzerland

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom